Crossmark

Wounding promotes ovarian cancer progression and decreases efficacy of cisplatin in a syngeneic mouse model

Crossref DOI link: https://doi.org/10.1186/s13048-018-0428-6

Published Online: 2018-07-04

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lee, Yooyoung

Kollara, Alexandra

May, Taymaa

Brown, Theodore J. https://orcid.org/0000-0002-3074-4516
Funding

Funding for this research was provided by:

CIHR grant (MOP106679)

Department of Obstetrics and Gynaecology (Mount Sinai Hospital/University Health Network Research Fund (2016-2017))
License Information

Text and Data Mining valid from 2018-07-04
More Information

Article History

Received: 8 May 2018

Accepted: 25 June 2018

First Online: 4 July 2018

Ethics approval

: All animal procedures were approved by the University of Toronto Animal Care and Use Committee.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.